You're using a free limited version of DrugPatentWatch: ➤ Start for $299 All access. No Commitment.

Last Updated: April 1, 2026

Litigation Details for WhatsApp Inc. v. NSO Group Technologies Limited (N.D. Cal. 2019)


✉ Email this page to a colleague

« Back to Dashboard


Small Molecule Drugs cited in WhatsApp Inc. v. NSO Group Technologies Limited
The small molecule drugs covered by the patents cited in this case are ⤷  Start Trial , ⤷  Start Trial , ⤷  Start Trial , ⤷  Start Trial , and ⤷  Start Trial .

Details for WhatsApp Inc. v. NSO Group Technologies Limited (N.D. Cal. 2019)

Date Filed Document No. Description Snippet Link To Document
2019-10-29 29 Exhibit 3 to Declaration of Joseph D. Mornin quot;the `070 atent") U.S. Patent No. 6,147,103 October• 9, 2018 (&…960 patent, the `424 patent, the `103 patent, the `213 patent, the `148 patent, or the `810 patent -- …230 patent, Che `960 patent, the `424 patent, the `103 patent, the `213 patent, the `1~8 patent, the `810…872 patent; the `810 patent; the `085 patent; and U.S. Patent No. 5,948,789("the `789 patent"…the `960 patent, the `424 patent, the `103 patent, the `213 patent, and the `148 patent. Thus, these External link to document
>Date Filed >Document No. >Description >Snippet >Link To Document

Litigation Summary and Analysis: WhatsApp Inc. v. NSO Group Technologies Limited (4:19-cv-07123-PJH)

Last updated: February 4, 2026


What Are the Key Facts of the Case?

WhatsApp Inc., owned by Meta Platforms Inc., filed the lawsuit against NSO Group Technologies Limited in September 2019. The complaint alleges that NSO Group, an Israeli cybersecurity company, utilized its Pegasus spyware to target and surveil thousands of WhatsApp users globally. The case involves allegations of unauthorized access, hacking, and violations of the Computer Fraud and Abuse Act (CFAA), among other claims.

  • Parties: WhatsApp Inc. v. NSO Group Technologies Limited
  • Case number: 4:19-cv-07123-PJH
  • Filed: September 20, 2019
  • Jurisdiction: Northern District of California, San Francisco division
  • Claims: Unlawful access to devices, intrusion, conspiracy, and violations of the U.S. CFAA, among others.

What Are the Primary Legal Claims?

  1. Unlawful Access Under CFAA: WhatsApp alleges NSO designed tools to bypass device security, enabling unauthorized access to user devices and data.

  2. Invasion of Privacy: Victimized users' communications and personal data were targeted without consent.

  3. Conspiracy and Aiding and Abetting: NSO allegedly collaborated with third parties to facilitate surveillance activities.

  4. Tortious Interference: The spyware's deployment allegedly interfered with users’ rights to privacy and quiet enjoyment of devices.

What Evidence Supports WhatsApp's Allegations?

  • Technical data: Indicators that Pegasus was utilized to exploit vulnerabilities in iOS and Android devices.
  • User reports: Evidence that at least 1,400 users across 20 countries were targeted.
  • Spyware Indicators: NSO claimed Pegasus was for government intelligence, but evidence suggests misuse against journalists, activists, and political figures.
  • Forensic Analysis: WhatsApp and external cybersecurity firms analyzed infected devices revealing Pegasus components and malicious code.

Legal Proceedings and Court Filings

  • WhatsApp filed an amended complaint in May 2020, amplifying claims about the scope of surveillance.
  • The case involves ongoing discovery negotiations, including subpoenas for NSO's internal communications.
  • NSO initially denied the allegations, asserting their spyware is for government law enforcement and counter-terrorism.

What Is the Current Status?

  • Motion Practice: Several motions, including dismissals and dispositive motions, are pending.
  • Discovery: Ongoing, with disputes over confidentiality and scope.
  • Settlement Discussions: No public record of settlement; litigation remains active.

What Are the Implications for the Cybersecurity Industry?

  • Legal Risks: Companies providing surveillance tools face civil litigation and potential criminal exposure.
  • Regulatory Scrutiny: Governments face increased pressure to scrutinize export controls on spyware.
  • Operational Risks: cybersecurity firms must implement stricter compliance mechanisms to prevent misuse.
  • Policy Impact: Proliferation of surveillance tools influences policy debates on privacy rights and human rights.

What Broader Historical and Regulatory Context Exists?

  • The case exemplifies conflicts between security interests and privacy rights.
  • The U.S. government classifies NSO’s Pegasus as a (entity) with export restrictions.
  • International pressure increased since 2019, with multiple governments emphasizing restrictions on spyware sales.

What Is the Outlook for the Litigation?

Expect extensive discovery, including subpoenas for NSO’s source code and corporate communications. Pending dispositive motions may resolve some claims. Legal action may expand to include claims against third-party vendors or government actors involved in the end-use.


Key Takeaways

  • The lawsuit marks one of the most high-profile legal efforts challenging spyware companies’ practices.
  • Ongoing discovery and motions will shape potential liability for NSO.
  • The case underscores increasing accountability risks for producers of government surveillance tools.
  • Regulatory actions, including export restrictions, are likely to intensify.

FAQ

1. What specific allegations does WhatsApp make regarding Pegasus?
WhatsApp alleges Pegasus exploits device vulnerabilities to install spyware without user consent, enabling unauthorized data collection.

2. Are there similar cases against other spyware companies?
Yes, law enforcement and civil rights groups have filed complaints or issued reports against companies like NSO and Cytrox for misuse.

3. What protections does U.S. law provide against hacking tools like Pegasus?
U.S. laws include CFAA, the Wiretap Act, and export controls, all of which could criminalize unauthorized surveillance activities.

4. How has the international community responded?
Several governments have imposed restrictions or bans on NSO and similar entities, citing human rights concerns.

5. When might this litigation conclude?
Litigation could extend for several years due to complex discovery, potential settlement negotiations, and appeals.


References

[1] 4:19-cv-07123-PJH, U.S. District Court, Northern District of California
[2] Reuters, "WhatsApp sues NSO over spying campaign," May 2020.
[3] The New York Times, "WhatsApp Accuses Israeli Spy Firm of Targeting Users," May 2020.
[4] U.S. Dept. of Commerce, Entity List, NSO Group, 2021.

More… ↓

⤷  Start Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.